SCHEMBL13805546

SCHEMBL13805546

O=C(Nc1ccc(O)c(C(=O)O)c1)c1ccc(-c2ccc(C(=O)Oc3ccc(O)c(C(=O)O)c3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 2/20 0.53
▸ TDP1 Q9NUW8 2/20 0.52
▸ GALK1 P51570 1/20 0.52
▸ CASP6 P55212 1/20 0.52
▸ MCL1 Q07820 1/20 0.52
▸ PLEC Q15149 1/20 0.52
▸ KMT2A Q03164 5/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ MAPT P10636 6/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ POLB P06746 3/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ ATM Q13315 1/20 0.51
▸ NR1H4 Q96RI1 1/20 0.49
▸ LMNA P02545 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HPSE Q9Y251 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13805528 0.87 SIRT6 (0.65) SIRT6TDP1MCL1KMT2AMEN1
SCHEMBL10758235 0.83 SIRT6 (0.64) SIRT6TDP1GALK1CASP6MCL1
SCHEMBL7706007 0.79 TOP1 (0.62) SIRT6TDP1MCL1KMT2AMEN1
SCHEMBL7030719 0.77 KMT2A (0.60) TDP1MCL1KMT2AMEN1MAPT
SCHEMBL1129948 0.77 KMT2A (0.77) SIRT6TDP1KMT2AMEN1MAPT
SCHEMBL10759208 0.76 MITF (0.64) SIRT6TDP1KMT2AMEN1MAPT
SCHEMBL31376926 0.76 SIRT6 (0.62) SIRT6TDP1KMT2AMEN1MAPT
SCHEMBL9150565 0.75 KDM4E (0.71) SIRT6TDP1KMT2AMEN1MAPT
SCHEMBL9150180 0.74 ALDH1A1 (0.84) MCL1KMT2AMEN1MAPTKDM4E
SCHEMBL14184959 0.74 MAPK1 (0.58) KMT2AMEN1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090162280-A1 DETECTING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2009-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090162280-A1 DETECTING SOLUBLE A-BETA F13B, FGB, IL1A SIRT6 4055/4885TDP1 3070/4885GALK1 2692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback